• Joana Tenreiro Pinto, Frederico C Pereira, Maria C Loureiro, Ricardo Gama, and Hugo L Fernandes.
• Department of Anesthesiology, Centro Hospitalar Tondela, Viseu, Portugal.
• Pharmacology. 2018 Jan 1; 101 (5-6): 290-297.

Background/AimsSeveral guidelines for neuropathic pain management and various effective drugs are available; however, neuropathic pain remains undertreated. This retrospective study aimed to evaluate the efficacy of topical capsaicin 8% in peripheral neuropathic pain in a routine clinical setting.MethodsTherapeutic efficacy was evaluated through pain intensity, using numerical pain rating scale at baseline and 7-14 days after each treatment, and using pain treatment area (PTA) assessed immediately before each treatment.ResultsA total of 43 patients with either post-herpetic neuralgia or post-traumatic/post-surgical neuropathic pain were enrolled. The median percentage reduction in numerical pain rating scale score and in PTA was -40.0 (-50.0 to -33.3; 95% CI, bootstrap) and -35.1 (-50.9 to 3.4; 95% CI, bootstrap), respectively. Pain intensity and PTA were equally improved and reduced in both treated conditions.ConclusionThis study suggests that topical capsaicin 8% reduces peripheral neuropathic pain as well as treatment pain area.© 2018 S. Karger AG, Basel.

20 keywords...

hide…